Xueheng Zhao

Xueheng Zhao, PhD


  • Member, Division of Pathology and Laboratory Medicine
  • Assistant Professor, UC Department of Pediatrics

About

Biography

I’m a bioanalytical chemist. My laboratory work using mass spectrometry includes three complementary themes: metabolism, metabolomics and clinical chemistry. My lab develops new tools that support solving biological questions through collaboration with clinicians and basic scientists. We are developing analytical methodologies tailored to biomarker discovery, particularly in the early diagnosis and treatment of pediatric genetic disorders, lysosomal storage and liver diseases. Additionally, my group engineers bioinformatic tools designed for lipidomic and metabolomics projects to enhance batch effect correction, metabolite identification and network analysis.

As a graduate student at the University of Georgia, I used ion trap mass spectrometry to determine biodegradation products from potentially carcinogenic azo dyes by microorganisms. I was amazed by mass spectrometry’s capability to measure metabolites sensitively and quantitatively and uncover unknown biological pathways. This led to my continued interest in mass spectrometry-based research.

Metabolic reprogramming and perturbation by genetic and environmental factors are key characteristics of cancer and metabolic diseases, including neurofibromatosis (NF) and metabolic dysregulation-associated fatty liver disease (MAFLD). A primary interest of my research is using mass spectrometry and -omics approach to discover novel biomarkers and dysregulated metabolic pathways to improve treatment for these refractory diseases.

My research uses lipidomics profiling to discover the metabolic links of the Fanconi anemia (FA) pathway and glycosphingolipid metabolism in head and neck cancer cells, published in Clinical Cancer Research. I also identified distinct bile acid signatures in undernourished children with environmental enteric dysfunction (EED), published in the Journal of Nutrition.

I’m honored to have been awarded a National Library of Medicine Fellowship at Stanford University. I have been a researcher for over 20 years and began working at Cincinnati Children’s in 2007.

Services and Specialties

Pathology

Interests

Lipidomics and metabolomics; mass spectrometry; metabolism

Publications

Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold-stored platelets. Hegde, S; Akbar, H; Wellendorf, AM; Nestheide, S; Johnson, JF; Zhao, X; Setchell, KD; Zheng, Y; Cancelas, JA. Blood. 2024; 144:1732-1746.

Machine-learning-based integrative -'omics analyses reveal immunologic and metabolic dysregulation in environmental enteric dysfunction. Zulqarnain, F; Zhao, X; Setchell, KD R; Sharma, Y; Fernandes, P; Srivastava, S; Shrivastava, A; Ehsan, L; Jain, V; Raghavan, S; Brown, DE; Moore, SR; Ali, SA; Syed, S. iScience. 2024; 27:110013.

Ceramides Are Elevated in Transplant-Associated Thrombotic Microangiopathy in Hematopoietic Stem Cell Transplant Recipients and Are a Druggable Target for Prophylaxis. Koo, J; Langenberg, L; Luebbering, N; Strecker, L; Abdullah, S; Carusone, E; Deavy, M; Hoerth, C; Miller, G; Turner, D; Ziady, AG; Myers, KC; Jodele, S; Davies, SM. Transplantation and Cellular Therapy. 2024; 30:s17-s18.

Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Zhao, X; Setchell, KD R; Carr, E; Arce-Clachar, AC; Bramlage, K; Huang, R; Fei, L; Beck, AF; Fawaz, R; Valentino, PL; Xanthakos, SA; Mouzaki, M. The Journal of Pediatrics. 2024; 265:113818.

Use of volumetric absorptive microsampling and parallel reaction monitoring mass spectrometry for tacrolimus blood trough measurements at home in pediatric heart transplant patients. Zhao, J; Setchell, KD R; Zhao, X; Galandi, S; Garr, BA N; Gao, Z; Chin, C; Stark, S; Steele, PE; Ryan, TD. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2024; 31:1-7.

Upregulation of acid ceramidase contributes to tumor progression in tuberous sclerosis complex. Astrinidis, A; Li, C; Zhang, EY; Zhao, X; Zhao, S; Guo, M; Olatoke, T; Mattam, U; Huang, R; Zhang, AG; Setchell, KD R; McCormack, FX; Xu, Y; Yu, JJ. JCI insight. 2023; 8:e166850.

Essential Fatty Acid Deficiency Associates with Growth Faltering and Environmental Enteric Dysfunction in Children. Narvaez-Rivas, M; Setchell, KD R; Galandi, SL; Zhao, X; Iqbal, NT; Ahmed, S; Iqbal, J; Syed, S; Ali, SA; Moore, SR. Metabolites. 2023; 13:489.

A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Barnard, ND; Kahleova, H; Holtz, DN; Znayenko-Miller, T; Sutton, M; Holubkov, R; Zhao, X; Galandi, S; Setchell, KD R. Menopause: The Journal of the North American Menopause Society. 2023; 30:80-87.

A Circulating Microbial Metabolite Drives the Clonal Expansion of Pre-Leukemic Cells. Agarwal, P; Sampson, A; Hueneman, K; Choi, K; Zhao, X; Galloway-Pena, J; Setchell, K; Starczynowski, DT. Blood. 2022; 140:975-976.

Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency. Zhao, X; Zhang, W; Vig, P; Kostrub, C; Setchell, KD R. Metabolites. 2022; 12:952.